A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION904

NCT04731623 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: ION904
DRUG: Placebo

Sponsor

Ionis Pharmaceuticals, Inc.